Advances in Chronic Kidney Disease
Volume 17, Issue 1 , Pages 19-25, January 2010

HIV and CKD Epidemiology

  • Jonathan A. Winston

      Affiliations

    • Corresponding Author InformationAddress correspondence to Jonathan Winston, MD, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1243, New York, NY 10029.

Mount Sinai School of Medicine, New York, NY

Nephrologists can serve many important functions for HIV-infected patients, including identifying risks for developing kidney disease, detecting and diagnosing kidney disease, distinguishing antiretroviral-induced kidney injury from kidney disease in the setting of antiretroviral therapy, comanaging the clinical course and complications of CKD, and preparing patients for dialysis and/or transplantation. The epidemiology of kidney disease in HIV informs us for these functions by describing the natural history of disease, its frequent occurrence in high-risk communities, and its potential causes. Risk factors that drive CKD in HIV are black race, hypertension, diabetes, HIV viral replication with low CD4 cell counts, high viral load or acquired immune deficiency syndrome–defining conditions, and antiretroviral agents with nephrotoxic potential. The prevalence of these risk factors in any population determines the magnitude of the problem, which can range from as low as 2% to as high as 30%. Recent research focuses on kidney health in HIV. Important links between HIV viral replication and glomerular filtration rate, even in patients with normal kidney function, are now being reported. A review of these data provides the foundation for a better understanding of kidney disease and, hopefully, better treatment for patients with HIV.

Key Words: HIV-associated nephropathy, CKD, Proteinuria, Hypertension

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Winston is a member of the Speaker's Bureau of Gilead Sciences. He receives consulting and lecture fees.

PII: S1548-5595(09)00165-7

doi:10.1053/j.ackd.2009.08.006

Advances in Chronic Kidney Disease
Volume 17, Issue 1 , Pages 19-25, January 2010